Showing results (141-150 of 255) with videos related to
Sort By:
Pageof 26
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 15, 2011
Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous systemMohamed H Farah, Bao Han Pan, Paul N Hoffman, et al.Cancer Research|April 19, 2011
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in miceKrystyna M Wozniak, Kenichi Nomoto, Rena G Lapidus, et al.Biorxiv : the Preprint Server for Biology|March 3, 2023
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosisSadiya Parveen, Jessica Shen, Shichun Lun, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
The discovery and structure-activity relationships of indole-based inhibitors of glutamate carboxypeptidase IIBrian Grella, Jessica Adams, James F Berry, et al.Biochemical Pharmacology|October 22, 2021
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryCarolyn Tallon, Silvia Picciolini, Seung-Wan Yoo, et al.Journal of Medicinal Chemistry|December 12, 2017
Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use DisordersMu-Fa Zou, Jianjing Cao, Ara M Abramyan, et al.Translational Oncology|July 25, 2019
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastomaAllison R Hanaford, Jesse Alt, Rana Rais, et al.Cancers|March 10, 2022
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine PathwaysKhoa Pham, Allison R Hanaford, Brad A Poore, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 5, 2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel diseaseAbhijit A Date, Rana Rais, Taarika Babu, et al.Journal of Medicinal Chemistry|May 12, 2006
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chainPavel Majer, Bunda Hin, Doris Stoermer, et al.Pageof 26